SINO BIOPHARMACEUTICAL Aktie

 

The trend of Chinese biotech companies licensing their products overseas has driven strong share price performance in 1H25, Goldman Sachs published a research report saying. Recently, discussions emerged regarding the sustainability of transactions and valuations. The broker believed that, after an in-depth analysis of licensing......

Daix (France), New York City (New York, United States), July 7, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the receipt of a $10 million milestone payment from Chia Tai-Tianqing Pharmaceutical Group Co., Ltd (“CTTQ”), a subsidiary of Sino Biopharm. This milestone payment follows the successful settlement of the second tranche of €115.6 million1 in gross proceeds (net proceeds of €108.5 million) of the previously announced structured financing of up to €348 million2 (the “Structured Financing”).In September 2022, Inventiva entered into a licensing and collaboration agreement with CTTQ (as amended on October 11, 2024, the “CTTQ License Agreement”) to develop and commercialize lanifibranor, Inventiva's proprietary compound, for the treatment of MASH and pote...

Stocks | Ratings | Target Prices AstraZeneca (AZN.US) | Buy | USD93.3 BEIGENE (06160.HK) | Buy | HKD208.8 HANSOH PHARMA (03692.HK) | Buy | HKD33 INNOVENT BIO (01801.HK) | Buy | HKD84 SINO BIOPHARM (01177.HK) | Buy | HKD5.9 SKB BIO-B (06990.HK) | Buy | HKD400 Legend Biotech (LEGN.US) | Buy | USD65 WUXI XDC (02268.HK) | Buy | HKD5......

The Chinese biotech industry entered a phase of accelerated growth, with companies expanding their innovative commercial product portfolios, nailing major out-licensing deals, and exceeding expected profitability, UOB Kay Hian's research report said.Ongoing policy support and globalization efforts will further foster the ind......

Hong Kong stocks swung between gains and losses after China reported a mixed bag of economic data from May. The Hang Seng Index rose 0.1 per cent to 23,907.52 as of 10.23am local time. The Hang Seng Tech Index gained 0.4 per cent. On the mainland, the CSI 300 Index climbed 0.1 per cent, and the Shanghai Composite Index added 0.2 per cent. Drug companies led the decline. Wuxi Biologics slumped 6.3 per cent to HK$26.30, Sinopharm Group lost 4 per cent to HK$18.44 and Sino Biopharmaceutical......

SINO BIOPHARM (01177.HK) announced that the proportion of revenue from the Group’s innovative products has risen from 16% in 2018 to 42% in 2024, with expectations to exceed 50% in 2025, marking a successful milestone in the Group’s innovation transformation.Over the next three years, the Group plans to launch around......

At close, HSI dropped 331 pts or 1.4% to 24,035. HSTI dropped 119 pts or 2.2% to 5,331. HSCEI fell 135 pts or 1.5% to 8,729. Market turnover reached $244.41 billion.Active Heavyweights:BABA (09988.HK) closed at $114.6, down 3.2%HKEX (00388.HK) closed at $411.4, down 2.1%MEITUAN (03690.HK) closed at $141, down 1.9%AIA (01299.HK) ......

The HSI dropped 121 points or 0.5% to 24,244 at midday. The HSCEI lost 45 points or 0.5% to 8,820. The HSTECH slipped 57 points or 1.1% to 5,393. Total half-day turnover of the market amounted to $125.639 billion.For carmakers, XPENG-W (09868.HK) stumbled 5%, although G7 pre-sale orders surpassed 10,000 units in 46 minutes of la......

At midday close, HSI dropped 121 pts or 0.5% to 24,244. HSTI dropped 57 pts or 1.1% to 5,393. HSCEI fell 45 pts or 0.5% to 8,820.Active Heavyweights:BABA (09988.HK) closed at $116, down 2%HKEX (00388.HK) closed at $417, down 0.8%CCB (00939.HK) closed at $7.71, up 0.8%, hitting new highPING AN (02318.HK) closed at $49.05, up 0.6%......

SINO BIOPHARM (01177.HK) opened 4.82% higher today (12th) and once peaked at HKD5.58. It last traded at HKD5.41, up 13.42%, on a volume of 254 million shares, involving HKD1.36 billion.Lei Ming, who is responsible for handling capital markets at SINO BIOPHARM, stated that out-licensing has become one of the company's key str......

SINO BIOPHARM (01177.HK) announced that TQB2868 injection “PD-1/TGF-β bi-functional fusion protein”, a Class 1 innovative drug developed by the Group, combined with anlotinib hydrochloride capsules and chemotherapy as first-line treatment for metastatic pancreatic ductal adenocarcinoma (mPDAC) demonstrated excel......

At close, HSI rose 141 pts or 0.6% to 23,654. HSTI rose 29 pts or 0.6% to 5,219. HSCEI gained 56 pts or 0.7% to 8,576. Market turnover reached $212.69 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $140.7, up 3%HKEX (00388.HK) closed at $403, up 1.9%, hitting new highAIA (01299.HK) closed at $66.05, down 1.4%PING AN (0......

At midday close, HSI rose 168 pts or 0.7% to 23,680. HSTI rose 52 pts or 1.0% to 5,241. HSCEI gained 74 pts or 0.9% to 8,594.Active Heavyweights:MEITUAN (03690.HK) closed at $142.2, up 4.1%HKEX (00388.HK) closed at $402.8, up 1.9%, hitting new highPING AN (02318.HK) closed at $45.8, down 1.4%BABA (09988.HK) closed at $115.4, up ......

Hong Kong stocks continued its uptrend from the previous day. The HSI slightly opened 12 points lower this morning (4th) before hiking in the early session, and last added 132 points or nearly 0.6% to 23,645, with a turnover of $71.025 billion.Pharma led the incline. CSPC PHARMA (01093.HK) and SINO BIOPHARM (01177.HK) escalated ......

At midday close, HSI dropped 348 pts or 1.5% to 23,224. HSTI dropped 134 pts or 2.5% to 5,166. HSCEI fell 146 pts or 1.7% to 8,413.Active Heavyweights:BABA (09988.HK) closed at $113, down 4.3%TENCENT (00700.HK) closed at $499.4, down 2.2%MEITUAN (03690.HK) closed at $138, down 1.5%HKEX (00388.HK) closed at $394.8, down 1.4%AIA (......

At close, HSI rose 315 pts or 1.4% to 23,573. HSTI rose 127 pts or 2.5% to 5,301. HSCEI gained 115 pts or 1.4% to 8,559. Market turnover reached $226.86 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $140.1, up 6.6%HKEX (00388.HK) closed at $400.4, up 2.4%, hitting new highBABA (09988.HK) closed at $118.1, up 2.1%TENCE......

The H shares of pharma inclined today (29th). SINO BIOPHARM (01177.HK) advanced 5.5% to $4.42, while CSPC PHARMA (01093.HK) surged 11.6% after announcing its 1Q results. AKESO (09926.HK) leaped 4%, while WUXI APPTEC (02359.HK) swelled 6.6%. WUXI BIO (02269.HK) shot up 9.8%.The 2025 annual meeting of American Society of Clinical ......

FDA Approves Chinese Non-Opioid Painkiller Alternative To Morphine That Could Reduce Fentanyl Overdoses As it relates to fentanyl, it looks the problem - and possibly the solution - could both be coming from China. The FDA has approved Qamzova, the first China-developed non-opioid painkiller, offering a potential tool to help reduce fentanyl-related overdose deaths. Created by Nanjing-based biotech firm Delova, Qamzova is the world's first long-acting injectable analgesic, providing 24-hour pain relief with a single daily dose. The drug is a high-concentration form of meloxicam, a non-steroidal anti-inflammatory (NSAID) in the same class as ibuprofen and aspirin, according to the South China Morning Post. The SCMP writes that it is described by Sino Biopharm as “the best available alternative to morphine,” clinical trials showed Qamzova nearly halved morphine use and lowered pain scores after orthopedic and abdominal surgeries. Approved in both the U.S. and China for post-operative pai...

At midday close, HSI rose 135 pts or 0.6% to 23,679. HSTI rose 31 pts or 0.6% to 5,283. HSCEI gained 64 pts or 0.8% to 8,622.Active Heavyweights:MEITUAN (03690.HK) closed at $138.1, up 1.5%CCB (00939.HK) closed at $7.04, up 1%, hitting new highHKEX (00388.HK) closed at $389.2, up 0.9%TENCENT (00700.HK) closed at $518.5, up 0.4%B......

At midday close, HSI rose 301 pts or 1.3% to 23,634. HSTI rose 69 pts or 1.3% to 5,324. HSCEI gained 110 pts or 1.3% to 8,570.Active Heavyweights:BABA (09988.HK) closed at $122.2, up 2.5%AIA (01299.HK) closed at $67.25, up 2.5%MEITUAN (03690.HK) closed at $135.4, up 0.7%CCB (00939.HK) closed at $6.9, up 0.7%HKEX (00388.HK) close......